Camlin Fine Sciences Limited announced its Q2 2025 financial results on November 10, 2025, detailing both consolidated and standalone figures for the quarter ending September 30, 2025. The company held a conference call to discuss these results, which was led by Chairman and Managing Director Mr. Ashish Dandekar, along with Managing Director Mr. Nirmal Momaya and Chief Financial Officer Mr. Santosh Parab. The audio recording of the call is now accessible on the company's official website, providing stakeholders with insights into the financial performance.

The announcement was made in accordance with Regulation 30(6) of the SEBI LODR, ensuring transparency and compliance with the Securities and Exchange Board of India’s regulations. Camlin Fine Sciences emphasized that the discussions during the call were based solely on publicly available information, with no unpublished price-sensitive information disclosed. This commitment to regulatory compliance underscores the company’s dedication to maintaining trust with its investors and the broader financial community.